Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders
Mov Disord Clin Pract
.
2020 Apr 16;7(4):357-360.
doi: 10.1002/mdc3.12953.
eCollection 2020 May.
Authors
Stella M Papa
1
,
Patrik Brundin
2
,
Victor S C Fung
3
,
Un Jung Kang
4
,
David J Burn
5
,
Carlo Colosimo
6
,
Han-Lin Chiang
7
,
Roy N Alcalay
8
,
Claudia Trenkwalder
9
;
MDS‐Scientific Issues Committee
Affiliations
1
Yerkes National Primate Research Center, Department of Neurology Emory University School of Medicine Atlanta Georgia USA.
2
Van Andel Institute, Center for Neurodegenerative Science Grand Rapids Michigan USA.
3
Movement Disorders Unit, Department of Neurology Westmead Hospital and Sydney Medical School, University of Sydney Sydney NSW Australia.
4
Department of Neurology New York University Grossman School of Medicine New York New York USA.
5
Department of Medical Sciences Newcastle University Medical School Newcastle United Kingdom.
6
Department of Neurology Santa Maria University Hospital Terni Italy.
7
Department of Neurology Neurological Institute, Taipei Veterans General Hospital Taipei Taiwan.
8
Department of Neurology Columbia University Irving Medical Center New York New York USA.
9
Paracelsus-Elena Klinik, Kassel, Department of Neurosurgery University Medical Center Goettingen Goettingen Germany.
PMID:
32373651
PMCID:
PMC7197322
DOI:
10.1002/mdc3.12953
No abstract available
Keywords:
COVID‐19; Parkinson's disease; SARS‐CoV‐2; coronavirus; movement disorders; pandemic.
Grants and funding
R21 NS110416/NS/NINDS NIH HHS/United States